SCHEMBL327463

SCHEMBL327463

CCNc1ccc(CC)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
MEN1 O00255 1/20 0.57
APAF1 O14727 1/20 0.57
USP2 O75604 1/20 0.57
ALDH1A1 P00352 1/20 0.57
POLB P06746 1/20 0.57
GAA P10253 1/20 0.57
ALOX15 P16050 1/20 0.57
ALOX12 P18054 1/20 0.57
MAPK1 P28482 1/20 0.57
CASP1 P29466 1/20 0.57
BLM P54132 1/20 0.57
KMT2A Q03164 1/20 0.57
HSD17B10 Q99714 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
CXCR4 P61073 1/20 0.53
RPS6KA2 Q15349 1/20 0.47
LMNA P02545 2/20 0.47
ADRA2A P08913 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL526383 0.86 MAPT (0.58) MAPTHPGDMEN1APAF1USP2
SCHEMBL1644806 0.84 HPGD (0.50) MAPTHPGDMEN1APAF1USP2
Hydrochloric Acid SCHEMBL9181167 0.83 MAPT (0.56) MAPTHPGDMEN1APAF1USP2
SCHEMBL19227694 0.82 ADRA2A (0.47) MAPTHPGDMEN1APAF1USP2
SCHEMBL12895818 0.82 ADRA2A (0.50) MAPTHPGDMEN1APAF1USP2
SCHEMBL8060137 0.82 MEN1 (0.80) MAPTHPGDMEN1APAF1USP2
SCHEMBL7052939 0.80 MAPT (0.50) MAPTHPGDMEN1APAF1USP2
SCHEMBL3097589 0.80 ADRA2A (0.48) MAPTHPGDMEN1APAF1USP2
SCHEMBL7052715 0.80 MAPT (0.45) MAPTHPGDMEN1APAF1USP2
SCHEMBL7052718 0.80 ADRA2A (0.48) MAPTHPGDMEN1APAF1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3773735-B1 CONJUGATE OF CYTOTOXIC DRUG AND PRODRUG FORM OF SAID CONJUGATE SYNDIVIA (FR) 2024-07-10 EP disclosed
EP-4122926-A1 TRIAZINE DERIVATIVE HAVING VIRUS PROPAGATION INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME Shionogi & Co., Ltd (JP) 2023-01-25 EP disclosed
CN-107207983-B Use of a lubricating composition 国际壳牌研究有限公司 2022-11-18 CN disclosed
US-20210219551-A1 Compositions for Inhibition of Insect Sensing VANDERBILT UNIVERSITY 2021-07-22 US disclosed
US-11008290-B2 Halogenated quinoline derivatives as antimicrobial agents UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) 2021-05-18 US disclosed
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10813355-B2 Compositions for inhibition of insect sensing VANDERBILT UNIVERSITY (US) 2020-10-27 US disclosed
WO-2020214336-A2 SULFUR-HETEROCYCLE EXCHANGE CHEMISTRY AND USES THEREOF UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2020-10-22 WO disclosed
US-10752617-B2 Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T)) GALDERMA RESEARCH & DEVELOPMENT (FR) 2020-08-25 US disclosed
US-10752617-B2 Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T)) GALDERMA RESEARCH & DEVELOPMENT (FR) 2020-08-25 US disclosed
EP-0240631-A1 Alkylation of amines and amides ETHYL CORPORATION (US) 1987-10-14 EP disclosed
US-4626592-A WITH A CYCLIC ETHER AND B-SUBGROUP METAL OXIDE ALKYLATION CATALYST ETHYL CORPORATION (US) 1986-12-02 US disclosed
US-4613705-A Catalytic alkylation of aromatic amines with alkanols ETHYL CORPORATION (US) 1986-09-23 US disclosed
US-4605766-A REACTING AROMATIC AMINES WITH ETHERS IN PRESENCE OF CATALYST CONTAINING IRON OXIDE ETHYL CORPORATION (US) 1986-08-12 US disclosed
US-4599449-A POSSIBLE RECOVERY OF UNUSED ALCOHOL ETHYL CORPORATION (US) 1986-07-08 US disclosed
EP-0073277-B1 PROCESS FOR PRODUCING ORTHOALKYLATED AROMATIC AMINES MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1985-07-17 EP disclosed
EP-0148009-A2 Process for the alkylation of aromatic amines and use of the products thereof ETHYL CORPORATION (US) 1985-07-10 EP disclosed
EP-0073277-A1 Process for producing orthoalkylated aromatic amines MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1983-03-09 EP disclosed
US-4351958-A Process for producing orthoalkylated aromatic amine MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1982-09-28 US disclosed
US-3968188-A Process for preparing the pentaerythritol ester of phosphorohalidous acid MONSANTO COMPANY (US) 1976-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10813355-B2 Compositions for inhibition of insect sensing OR51E2, TRPA1, OR10J3 MAPT 2086/4885HPGD 4292/4885MEN1 1871/4885
US-10752617-B2 Indazole sulfonamide derivatives as inverse agonists of retinoid-related orphan receptor gamma (ROR gamma (T)) RORA, RORB, RORC MAPT 664/4885HPGD 983/4885MEN1 4867/4885
US-20210219551-A1 Compositions for Inhibition of Insect Sensing OR51E2, TRPA1, OR10J3 MAPT 1741/4885HPGD 4384/4885MEN1 1675/4885
US-11008290-B2 Halogenated quinoline derivatives as antimicrobial agents NDUFS5, NDUFS7, NDUFS3 MAPT 4764/4885HPGD 1555/4885MEN1 1670/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.